<DOC>
	<DOCNO>NCT00095498</DOCNO>
	<brief_summary>This study determine efficacy , safety , tolerability denosumab ( AMG 162 ) treatment Rheumatoid Arthritis ( RA ) .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability Denosumab Treatment Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<criteria>Diagnosis RA . All subject require take stable dose methotrexate . Active RA screening define great equal 6 swollen joint . The presence erosive disease Received biologic agent ( e.g. , Enbrel® , Remicade® , Humira® , Kineret® ) Arava® within 8 week randomization ; past use agent allow . Steroid use great 15 mg/day . Scheduled surgery joint replacement hand , wrists foot .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>arthritis</keyword>
	<keyword>joint pain</keyword>
	<keyword>Methotrexate</keyword>
</DOC>